This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Parata Systems, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Rongkai Xu
Introduction
Rongkai Xu is a notable inventor based in Morganville, NJ (US). He has made significant contributions to the field of drug product packaging through his innovative patent. His work focuses on enhancing the validation process of drug products, which is crucial for ensuring safety and compliance in the pharmaceutical industry.
Latest Patents
Rongkai Xu holds a patent titled "Methods, systems, and computer program product for removing extraneous content from drug product packaging to facilitate validation of the contents therein." This patent describes a method that involves receiving an image of a drug product package containing one or more drug products. The method utilizes an artificial intelligence engine to detect labeling content on the package's surface and generates a modified image with the labeling content removed. This innovation aims to streamline the validation process of drug products, making it more efficient and reliable.
Career Highlights
Rongkai Xu is currently employed at Parata Systems, LLC, where he continues to develop innovative solutions in the pharmaceutical sector. His expertise in artificial intelligence and image processing has positioned him as a valuable asset to his team and the industry at large.
Collaborations
Rongkai Xu collaborates with talented professionals such as John Alfred Bugay and Todd Martin Jenkins. Their combined efforts contribute to the advancement of technology in drug packaging and validation processes.
Conclusion
Rongkai Xu's innovative work in drug product packaging demonstrates the importance of technology in enhancing safety and compliance in the pharmaceutical industry. His contributions are paving the way for more efficient validation processes, ultimately benefiting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
